Characterizing QT interval prolongation in early clinical development: a case study with methadone

por Dubois, Vincent F. S., Danhof, Meindert, Della Pasqua, Oscar
Publicado en Pharmacol Res Perspect (2017)

Model-based evaluation of drug-induced QTc prolongation for compounds in early development

por Dubois, Vincent F S, Yu, Huixin, Danhof, Meindert, Della Pasqua, Oscar
Publicado en Br J Clin Pharmacol (2015)

Translating QT interval prolongation from conscious dogs to humans

por Dubois, Vincent F. S., Smania, Giovanni, Yu, Huixin, Graf, Ramona, Chain, Anne S. Y., Danhof, Meindert, Della Pasqua, Oscar
Publicado en Br J Clin Pharmacol (2016)

Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy

por González‐García, Ignacio, Pierre, Vadryn, Dubois, Vincent F. S., Morsli, Nassim, Spencer, Stuart, Baverel, Paul G., Moore, Helen
Publicado en CPT Pharmacometrics Syst Pharmacol (2021)

Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total

por Hood, John, González-García, Ignacio, White, Nicholas, Marshall, Leeron, Dubois, Vincent F. S., Vicini, Paolo, Baverel, Paul G.
Publicado en Pharmaceutics (2021)

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status

por Baverel, Paul G., Dubois, Vincent F.S., Jin, Chao Yu, Zheng, Yanan, Song, Xuyang, Jin, Xiaoping, Mukhopadhyay, Pralay, Gupta, Ashok, Dennis, Phillip A., Ben, Yong, Vicini, Paolo, Roskos, Lorin, Narwal, Rajesh
Publicado en Clin Pharmacol Ther (2018)